EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disease progression in probable limbic‐predominant age‐related TDP‐43 encephalopathy

Charlotte Moss, Lei Yu, Konstatinos Arfanakis, Ajay Sood iD, for Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & Dementia · 2026-11 · 22 (11)

DOI: 10.1002/alz.71954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.11.2026. Verfasst von Charlotte Moss und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Disease Progression, Alzheimer Disease, TDP-43 Proteinopathies. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Limbic‐predominant age‐related transactive response DNA‐binding protein of 43 kDa (TDP‐43) encephalopathy (LATE) is confirmed in post mortem examination by TDP‐43 pathology. Applying certain criteria, we examined cognitive trajectories in probable LATE and Alzheimer's disease (AD) participants compared with cognitively normal (CN) participants. METHODS From the Alzheimer's Disease Neuroimaging Initiative, 108 individuals were classified into AD, probable LATE, or CN groups based on cognitive status, amyloid beta/tau biomarkers, and hippocampal volume. Cognition was assessed prospectively after baseline. RESULTS Both probable LATE and AD showed faster decline than CN participants. The magnitude of decline was generally greater in AD than in probable LATE across cognitive domains. Annual rates of change were 0.81 and 2.08 for probable LATE and AD, respectively, on the Alzheimer's Disease Assessment Scale–Cognitive Subscale, 0.24 and 0.36 on the Clinical Dementia Rating Scale–Sum of Boxes, −0.50 and −0.72 on Logical Memory II, and 5.83 and 10.98 on Trail Making Test Part B. DISCUSSION These findings support the identification of probable LATE clinically and may inform diagnostic strategies and therapeutic trial design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionAlzheimer DiseaseTDP-43 ProteinopathiesHumansFemaleMaleAgedAged, 80 and overNeuropsychological TestsAmyloid beta-PeptidesDNA-Binding ProteinsHippocampusLimbic SystemDementia

Stichwörter der Autor:innen

Alzheimer's diseasecognitive assessmentsdementialimbic‐predominant age‐related TDP‐43 encephalopathymild cognitive impairment

Substanzen

Amyloid beta-PeptidesDNA-Binding Proteins

Autor:innen und Institutionen

  • Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
  • Department of Neurological Sciences, Rush University, Chicago, Illinois, USA.
  • Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, USA.

ORCID-Profile: Ajay Sood

Förderung

  • NIA NIH HHS

Zitieren

APA

Moss, C., Yu, L., Arfanakis, K., Sood, A., & for Alzheimer's Disease Neuroimaging Initiative (2026). Disease progression in probable limbic‐predominant age‐related TDP‐43 encephalopathy. Alzheimer's & Dementia, 22(11). https://doi.org/10.1002/alz.71954

Vancouver

Moss C, Yu L, Arfanakis K, Sood A, for Alzheimer's Disease Neuroimaging Initiative. Disease progression in probable limbic‐predominant age‐related TDP‐43 encephalopathy. Alzheimer's & Dementia. 2026;22(11). doi:10.1002/alz.71954

BibTeX
@article{Moss2026,
  author = {Moss, Charlotte and Yu, Lei and Arfanakis, Konstatinos and Sood, Ajay and for Alzheimer's Disease Neuroimaging Initiative, for Alzheimer's Disease Neuroimaging Initiative},
  title = {Disease progression in probable limbic‐predominant age‐related TDP‐43 encephalopathy},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {11},
  doi = {10.1002/alz.71954}
}
Kostenlos starten →